Pharmaceutical Products Companies By Held By Institutions

Shares Owned By Institutions
Shares Owned By InstitutionsEfficiencyMarket RiskExp Return
1DVAX Dynavax Technologies
99.67
 0.06 
 2.48 
 0.14 
2VCEL Vericel Corp Ord
99.08
 0.09 
 3.06 
 0.27 
3MRVI Maravai Lifesciences Holdings
98.63
(0.12)
 6.06 
(0.70)
4MLTX MoonLake Immunotherapeutics
98.14
 0.04 
 3.14 
 0.11 
5MRUS Merus BV
98.0
(0.13)
 2.10 
(0.27)
6MIRM Mirum Pharmaceuticals
97.76
 0.05 
 2.51 
 0.12 
7VERV Verve Therapeutics
97.7
 0.00 
 4.57 
(0.01)
8MLYS Mineralys Therapeutics, Common
97.4
 0.03 
 3.78 
 0.10 
9MRSN Mersana Therapeutics
95.35
 0.09 
 6.68 
 0.59 
10VERA Vera Therapeutics
94.71
 0.09 
 3.81 
 0.35 
11MGNX MacroGenics
93.4
(0.01)
 4.25 
(0.04)
12DNTH Dianthus Therapeutics
91.24
(0.12)
 3.68 
(0.45)
13DNLI Denali Therapeutics
90.58
 0.01 
 3.45 
 0.02 
14MDGL Madrigal Pharmaceuticals
85.2
 0.11 
 4.57 
 0.51 
15MRNS Marinus Pharmaceuticals
83.03
(0.04)
 12.75 
(0.52)
16VIGL Vigil Neuroscience
80.15
(0.05)
 3.63 
(0.18)
17VKTX Viking Therapeutics
75.43
(0.04)
 5.15 
(0.22)
18MRNA Moderna
71.56
(0.35)
 3.24 
(1.14)
19MNMD Mind Medicine
68.09
 0.08 
 4.69 
 0.36 
20MREO Mereo BioPharma Group
65.66
(0.11)
 3.42 
(0.37)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen. Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.